0001437749-26-010668
SEC filingNextPlat reported a 17% revenue decline to $54.3 million, though aggressive cost management and the absence of prior-year impairment charges narrowed the operating loss by 62% to -$9.0 million.
Gross profit declined 33% to $10.9 million, with gross margin compressing to 20.1%. The decrease in gross margin was attributable to the overall decline in gross profit in both operating segments. The company's significant levels of inventory stored in fulfillment centers around the world continue to support its ability to secure customer orders against competitors who may not hold available inventory.
Operating loss improved 62% to -$9.0 million from -$23.6 million in the prior year. The improvement reflects both the absence of prior-year impairment charges and ongoing cost reduction measures. In response to recent trends and in alignment with long-term strategic goals, management continues to implement cost reduction measures aimed at improving operational efficiency and preserving liquidity. Net loss narrowed 25% to -$10.5 million, with diluted EPS improving to -$0.44 from -$0.68.
Net cash used in operating activities was -$6.1 million, compared to -$5.5 million in the prior year. Capital expenditures decreased to $71,000 from $189,000, primarily due to a decrease in computer equipment purchases. Free cash flow was -$6.2 million. Principal uses of cash include purchases of pharmaceutical and e-Commerce inventory, operating expenses including payroll and professional services, technology development, and potential strategic investments. Operations require significant working capital to support inventory purchases, pharmaceutical procurement, and continued development of technology platforms.
The company disclosed two unremediated material weaknesses in internal controls related to PBM performance bonus receivable estimation and PIPE warrant modification accounting. Management has initiated remediation plans including enhanced review controls and engagement of third-party valuation specialists. Management continues to evaluate strategic alternatives and operational initiatives intended to strengthen the liquidity position and support long-term growth. If revenue growth does not occur at the pace anticipated, or if operating expenses increase more rapidly than expected, the company may be unable to achieve or sustain profitability.